Berkeley Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Sell
27,259
-943
-3% -$90.3K 0.55% 32
2025
Q4
$2.71M Sell
28,202
-3,792
-12% -$368K 0.64% 24
2025
Q3
$3.05M Buy
31,994
+376
+1% +$34.6K 0.72% 22
2025
Q2
$2.76M Buy
31,618
+361
+1% +$30.6K 0.7% 22
2025
Q1
$2.81M Buy
31,257
+12,061
+63% +$1.08M 0.77% 21
2024
Q4
$1.53M Sell
19,196
-10,271
-35% -$889K 0.43% 44
2024
Q3
$2.65M Buy
29,467
+1,838
+7% +$155K 0.76% 20
2024
Q2
$2.17M Buy
27,629
+1,446
+6% +$119K 0.65% 25
2024
Q1
$2.28M Buy
26,183
+6,996
+36% +$597K 0.7% 23
2023
Q4
$1.58M Buy
19,187
+797
+4% +$60.7K 0.52% 31
2023
Q3
$1.44M Buy
18,390
+395
+2% +$33.1K 0.52% 36
2023
Q2
$1.59M Buy
17,995
+1,165
+7% +$100K 0.56% 35
2023
Q1
$1.36M Buy
16,830
+1,471
+10% +$120K 0.5% 39
2022
Q4
$1.19M Buy
15,359
+3,343
+28% +$271K 0.46% 43
2022
Q3
$970K Buy
12,016
+3,146
+35% +$283K 0.42% 47
2022
Q2
$796K Buy
8,870
+1,721
+24% +$174K 0.33% 57
2022
Q1
$793K Buy
7,149
+4,115
+136% +$435K 0.32% 64
2021
Q4
$314K Buy
3,034
+1,034
+52% +$120K 0.13% 106
2021
Q3
$251K Buy
2,000
+105
+6% +$13.6K 0.12% 116
2021
Q2
$235K Sell
1,895
-154
-8% -$19.3K 0.1% 125
2021
Q1
$242K Hold
2,049
0.12% 111
2020
Q4
$240K Buy
+2,049
New +$226K 0.12% 107

Other funds holding MDT

Berkeley Capital Partners's MDT Position: Q1 2026 in Review

Berkeley Capital Partners reduced its Medtronic (MDT) stake by 3.3% in Q1 2026, selling an estimated $90.3K and leaving 27,259 shares worth $2.36M. The position accounts for 0.55% of the portfolio, ranked #32.

Berkeley Capital Partners first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.05M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Berkeley Capital Partners held 27,259 shares of Medtronic worth $2.36M as of Q1 2026.
  • Berkeley Capital Partners sold 943 Medtronic shares in Q1 2026, an estimated $90.3K.
  • Medtronic made up 0.55% of Berkeley Capital Partners's portfolio in Q1 2026, its #32 holding.
  • Berkeley Capital Partners first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
  • Berkeley Capital Partners's Medtronic position peaked at $3.05M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.